SCHEMBL7326664

SCHEMBL7326664

CCc1nc(Cl)c(Oc2ccccc2OC)c(N(CC(C)C)S(=O)(=O)c2ccccc2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHPS P49366 2/20 0.42
EDNRA P25101 3/20 0.41
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
LMNA P02545 2/20 0.37
HTT P42858 1/20 0.37
POLB P06746 1/20 0.37
HPGD P15428 1/20 0.37
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
GAA P10253 1/20 0.36
PKM P14618 1/20 0.36
ESR1 P03372 1/20 0.36
BCL2L1 Q07817 1/20 0.35
MCL1 Q07820 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8322432 0.89 LMNA (0.41) DHPSEDNRAMEN1KMT2ALMNA
SCHEMBL7332509 0.87 RORC (0.38) MEN1KMT2APOLBHPGDALDH1A1
SCHEMBL7292782 0.87 EDNRA (0.40) DHPSEDNRAMEN1KMT2ALMNA
SCHEMBL7302917 0.85 EDNRA (0.51) DHPSEDNRA
SCHEMBL7296309 0.84 EDNRA (0.39) DHPSEDNRA
SCHEMBL7303989 0.84 DHPS (0.47) DHPSEDNRAHTTPOLBMCL1
SCHEMBL7333240 0.84 EDNRA (0.50) DHPSEDNRA
SCHEMBL7293765 0.83 EDNRA (0.44) DHPSEDNRAMEN1KMT2ALMNA
SCHEMBL7297143 0.82 DHPS (0.42) DHPSEDNRAMCL1RORC
SCHEMBL7302684 0.82 DHPS (0.38) DHPSEDNRALMNARORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0526708-B1 Sulfonamide, preparation and use thereof as medicine and intermediate HOFFMANN LA ROCHE (CH) 2000-10-18 EP disclosed
EP-0526708-A1 Sulfonamide, preparation and use thereof as medicine and intermediate F. HOFFMANN-LA ROCHE AG (CH) 1993-02-10 EP disclosed